Drug intelligence / Profile preview

spironolactone

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Spironolactone is a synthetic steroidal antimineralocorticoid and potassium-sparing diuretic. It acts primarily as a competitive antagonist of the mineralocorticoid receptor, thereby inhibiting the effects of aldosterone in the distal renal tubules and collecting ducts. This leads to increased excretion of sodium and water while conserving potassium. Spironolactone also exhibits antiandrogenic activity by antagonizing androgen receptors and weak progestogenic/estrogenic effects due to its interaction with other steroid hormone receptors. Clinically, it is used for treating heart failure (especially NYHA class III-IV), hypertension (as add-on therapy), edema associated with liver cirrhosis or nephrotic syndrome, primary hyperaldosteronism (diagnosis and treatment), hypokalemia prevention/treatment, hirsutism in women, adult acne vulgaris, female pattern hair loss, polycystic ovary syndrome-related symptoms such as excess hair growth, and as part of feminizing hormone therapy for transgender women[1][2][4][5][6][7][9].

Brand names
AldactoneCaroSpir安体舒通阿尔达克通
Other names
螺内酯7α-acetylthiospirolactone
02

Targets

PR (Progesterone receptor)GR (Glucocorticoid receptor)AR (Adrenergic receptors)MR (Mineralocorticoid receptor)ER (Estrogen receptor)

Beyond the preview

Go deeper on spironolactone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on spironolactone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call